Supplements News and Research

RSS

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.

23 Nov 2020

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.

23 Nov 2020

Scientists investigate how cell membrane and COVID-19 virus impact each other

The cell membrane is the cell's outermost line of defense against SARS-CoV-2, the novel coronavirus responsible for COVID-19 disease.

20 Nov 2020

Vitamin D3 supplementation shows no therapeutic benefits in severe COVID-19 patients, study finds

A team of researchers at the University of São Paulo in Brazil aimed to determine if vitamin D3 supplementation reduces the length of stay in hospitalized patients with severe COVID-19.

18 Nov 2020

FDA approves first COVID-19 diagnostic test for at-home use

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and that provides rapid results.

18 Nov 2020

Two-thirds of older Americans would not seek treatment for depression, new poll shows

A new nationwide poll, the GeneSight Mental Health Monitor, shows that nearly two-thirds (61%) of Americans age 65 or older who have concerns about having depression will not seek treatment.

17 Nov 2020

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs).

17 Nov 2020

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.

17 Nov 2020

Lower choline in pregnant Black American women linked to higher levels of stress hormone

Researchers at the University of Colorado Anschutz Medical Campus have found that many pregnant Black Americans have low levels of choline, an essential nutrient that aids in prenatal brain development. Stress caused by institutional racism may play a role.

16 Nov 2020

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

The fish oil-based medication known as omega-3 carboxylic acids or omega-3 CA did not decrease the risk of cardiac events compared to a placebo, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

Taking omega-3 fatty acids and vitamin D3 supplements does not neither increase nor decrease the risk of developing atrial fibrillation, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Effectiveness of vitamin C against COVID-19 depends on its natural transporter levels

High doses of vitamin C under study for treating COVID-19 may benefit some populations, but investigators exploring its potential in aging say key factors in effectiveness include levels of the natural transporter needed to get the vitamin inside cells.

11 Nov 2020

Study examines the effects of simple measures on the health of active older adults

The DO-HEALTH study led by Zurich-based geriatrician Professor Heike Bischoff-Ferrari has examined the effects of simple measures on the health of healthy adults aged 70 or older.

10 Nov 2020

Perceived lack of social support affects a patient's ability to manage type 2 diabetes

New research reveals a perceived lack of support from family and friends affects a patient's ability to manage type 2 diabetes, according to a study published in The Journal of the American Osteopathic Association.

9 Nov 2020

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD).

8 Nov 2020

FDA releases final guidance to help identify and prevent insanitary conditions at compounders’ facilities

Protecting patients from exposure to poor quality compounded drugs is a fundamental part of the U.S. Food and Drug Administration's drug compounding program, and we are committed to protecting patients.

6 Nov 2020

Vitamin D supplements ease symptoms of severe atopic dermatitis in children

Vitamin D supplementation eased the symptoms experienced by children with severe atopic dermatitis, or eczema, in a recent randomized controlled trial published in Pharmacology Research & Perspectives.

4 Nov 2020

Collaborative effort will enable efficient oversight to prevent illegal, harmful products from entering the U.S.

Recently, leadership from the U.S. Food and Drug Administration, the U.S. Customs and Border Protection, and the U.S. Immigration and Customs Enforcement, Homeland Security Investigations signed a Memorandum of Understanding to stop harmful products that pose a threat to public health and attempt to enter the U.S. through International Mail Facilities.

30 Oct 2020

New process converts crustacean shells and wood waste into nutritional supplements

The shells of crustaceans and wood waste such as branches pruned from trees usually end up in landfills. These waste materials are given a new lease of life to become nutritional supplements and medicine, with the help of a novel process developed by researchers from the National University of Singapore (NUS).

30 Oct 2020

Supplements News and Research

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Scientists investigate how cell membrane and COVID-19 virus impact each other

Vitamin D3 supplementation shows no therapeutic benefits in severe COVID-19 patients, study finds

FDA approves first COVID-19 diagnostic test for at-home use

Two-thirds of older Americans would not seek treatment for depression, new poll shows

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

Lower choline in pregnant Black American women linked to higher levels of stress hormone

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

Effectiveness of vitamin C against COVID-19 depends on its natural transporter levels

Study examines the effects of simple measures on the health of active older adults

Perceived lack of social support affects a patient's ability to manage type 2 diabetes

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

FDA releases final guidance to help identify and prevent insanitary conditions at compounders’ facilities

Vitamin D supplements ease symptoms of severe atopic dermatitis in children

Collaborative effort will enable efficient oversight to prevent illegal, harmful products from entering the U.S.

New process converts crustacean shells and wood waste into nutritional supplements

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News